<!-- Is BPC-157 Legal in the U.S.? FDA, WADA and Research-Use Status (November 2026) | https://bpc157pens.com/bpc-157-legal-status/ -->

Guide · Regulation · As of November 2026

# Is BPC-157 legal in the _U.S.?_

**BPC-157 is not FDA-approved for any use. It is sold in the U.S. labeled for laboratory research use only.** In 2023 FDA flagged it as a compounding substance that may present significant safety risks. In July 2026 an FDA advisory committee voted 8–6 to recommend reversing that, but FDA has not finalized any change.[1](#src-1),[2](#src-2)

By the bpc157pens.com Editorial Team · Last reviewed November 15, 2026 · General information, not legal advice

## FDA _timeline_

FDA’s 2023 safety-risk listing still stands. The 2026 committee vote is a recommendation only, and any change requires FDA rulemaking.

1.  2023
    
    FDA places BPC-157 among bulk drug substances for compounding that may present significant safety risks, citing possible immune reactions, peptide impurities and limited safety information.[1](#src-1)
    
2.  July 23, 2026
    
    FDA’s Pharmacy Compounding Advisory Committee votes 8 to 6, with one abstention, to recommend adding BPC-157 to the list of substances compounding pharmacies may use. FDA’s own review staff had recommended against it.[2](#src-2),[3](#src-3)
    
3.  Today
    
    The vote is advisory. Rulemaking has not been completed, and BPC-157 remains unapproved.[2](#src-2),[3](#src-3)
    

## Sport and _military_

WADA · S0

### Prohibited at all times

The World Anti-Doping Agency lists BPC-157 under S0, non-approved substances, prohibited in and out of competition.[4](#src-4)

U.S. Department of Defense

### Prohibited for service members

Operation Supplement Safety lists BPC-157 as a prohibited peptide and an unapproved drug found in some wellness products.[5](#src-5)

## What “research use only” _means_

“Research use only” is a label for materials intended for laboratory work. It is not an FDA approval, and it does not make a product a drug, a dietary supplement or suitable for human use.

This page is general information, not legal advice. Rules can change; check FDA’s current guidance before relying on it.

## Sources

1.  U.S. Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks. [fda.gov](https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks)
2.  U.S. Food and Drug Administration. July 23–24, 2026: Meeting of the Pharmacy Compounding Advisory Committee. [fda.gov](https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026)
3.  The Hill. FDA panel votes to add peptides to permitted compounding list despite opposition from agency scientists. July 2026. [thehill.com](https://thehill.com/homenews/5987510-fda-committee-votes-peptides/)
4.  World Anti-Doping Agency. The Prohibited List. [wada-ama.org](https://www.wada-ama.org/en/prohibited-list)
5.  Operation Supplement Safety (U.S. Department of Defense). BPC-157: A prohibited peptide and an unapproved drug found in health and wellness products. [opss.org](https://www.opss.org/article/bpc-157-prohibited-peptide-and-unapproved-drug-found-health-and-wellness-products)
